Michael Kenison

Corporate Officer/Principal at PROTO LABS, INC.

Net worth: 702 268 $ as of 29/04/2024

Process Industries

Commercial Services

Michael Kenison active positions

Companies	Position	Start	End
PROTO LABS, INC.	Corporate Officer/Principal	31/05/2021	-

Companies	Position	Start	End
Cardiac Science, Inc. Cardiac Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cardiac has developed RHYTHMx ECD, technology that continuously monitors a patient's heart rhythm and provided defibrillation to help the organ keep a steady beat. Cardiac Science has used the technology to develop an external cardiac defibrillator, the Powerheart, which is used in hospitals. The firm also sold patient monitors and emergency defibrillators, and has developed a small portable defibrillator that can be used by patients in the hospital or at home. Cardiac Science markets its products in more than 50 countries worldwide.	Corporate Officer/Principal	-	-

International

United States

Operational

Corporate Officer/Principal

Sectoral

Process Industries	2
Commercial Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
PROTO LABS, INC.	Process Industries

Private companies	1
Cardiac Science, Inc. Cardiac Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cardiac has developed RHYTHMx ECD, technology that continuously monitors a patient's heart rhythm and provided defibrillation to help the organ keep a steady beat. Cardiac Science has used the technology to develop an external cardiac defibrillator, the Powerheart, which is used in hospitals. The firm also sold patient monitors and emergency defibrillators, and has developed a small portable defibrillator that can be used by patients in the hospital or at home. Cardiac Science markets its products in more than 50 countries worldwide.	Commercial Services

Private companies

Commercial Services